WebPhotocure is headquartered in Oslo, Norway and listed on the Oslo Stock Exchange (OSE: PHO). Photocure 4,973 followers on LinkedIn. The Bladder Cancer Company About … WebApr 12, 2024 · The Board of Directors of Photocure ASA has approved the annual accounts for 2024. The financial statements and annual report for the financial year 2024 are together with the ESG report and auditor's report attached to this notice. The ESEF file for 2024 is also attached. The documents are enclosed and also made available at the company's ...
ESG Report - mb.cision.com
WebMar 14, 2024 · OSLO, Norway, March 14, 2024 /PRNewswire/ -- Photocure ASA(OSE: PHO), the Bladder Cancer Company, announces its participation in the congress, and two abstract presentations at the European Association of Urology congress (EAU) in Milan, Italy, highlighting the benefits of Blue Light Cystoscopy (BLC ®) in Bladder Cancer … WebPhotocure ASA is a Norwegian specialty pharma company that develops and sells pharmaceuticals and medical devices based on proprietary photodynamic technology. … crypto tax harvesting guide
Photocure ASA: Results for the second quarter of 2024 - Yahoo
WebDec 27, 2024 · /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that its partner and exclusive distributor, Asieris MediTech in mainland China... WebPhotocure GmbH mit Sitz in Düsseldorf ist im Handelsregister mit der Rechtsform Gesellschaft mit beschränkter Haftung eingetragen. Das Unternehmen wird beim … WebApr 12, 2024 · Oslo, Norway, 12 April 2024: Photocure ASA (OSE: PHO), calls for the annual general meeting of Photocure ASA to be held on 3 May 2024 at 17:00 hours (CEST), virtual through the general meeting portal administered by Euronext Securities Oslo (the "Euronext Securities Portal"). ... 40477 Düsseldorf Germany. E-mail: ... crystal and fluid intelligence